AR and pachyonychia congenita: Recently, as a result of efforts that have been made in clinical and research fields to subtype metastatic CRPCs, a new subtype concept called “double-negative PC (DNPC)”, characterized by the lack of AR pathway activation or neuroendocrine (NE) traits, has emerged44,45.